EGFR FASTnet: The Italian network for epidermal growth factor receptors (EGFR) mutation analysis in non-small cell lung cancer (NSCLC)

被引:0
|
作者
Normanno, N.
Pinto, C.
Taddei, G. L.
Mari, E.
Troncone, G.
Graziano, P.
Mottolese, M.
Ludovini, V.
Zupo, S.
De Maglio, G.
Russo, A.
Larocca, L. M.
Di Maio, M.
Gambacorta, M.
Nappi, O.
Viale, G.
Ardizzoni, A.
Crino, L.
Perrone, F.
Marchetti, A.
机构
[1] INT Fdn Pascale, Naples, Italy
[2] St Orsola Marcello Malpighi Hosp, Bologna, Italy
[3] Univ Florence, Florence, Italy
[4] AstraZeneca, Res & Dev, Basiglio, Italy
[5] Univ Naples Federico II, Dept Biomorfol & Funct Sci, Naples, Italy
[6] Az Osp S Camillo Forlanini, Rome, Italy
[7] Regina Elena Inst Canc Res, Rome, Italy
[8] Osped S Maria Misericordia, Perugia, Italy
[9] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[10] Azienda Osped Univ Santa Maria Misericordia, Udine, Italy
[11] Policlin Palermo, Lab Oncol Mol, Dip Oncol, Palermo, Italy
[12] Univ Cattolica Sacro Cuore, Inst Pathol Anat, I-00168 Rome, Italy
[13] Natl Canc Inst, Naples, Italy
[14] Osped Niguarda Ca Granda, Milan, Italy
[15] AORN Cardarelli, Naples, Italy
[16] European Inst Oncol, Milan, Italy
[17] Azienda Osped Univ, Unita Oncol Med, Parma, Italy
[18] Azienda Osped Perugia, Perugia, Italy
[19] Univ G DAnnunzio, Ctr Predict Moleculr Med, SS Annunziata Hosp, Chieti, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18026
引用
收藏
页数:1
相关论文
共 50 条
  • [41] UTILITY OF TESTING FOR NON-SMALL CELL LUNG CANCER (NSCLC) EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS IN AN AUSTRALIAN TESTING PROGRAM
    Peters, M.
    Solomon, B.
    Bowden, J.
    Lewis, J.
    Carpenter, P.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S180 - S180
  • [42] PROFILING THE CLINICAL AND DIAGNOSTIC PATHWAY OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTANT NON-SMALL CELL LUNG CANCER (NSCLC) IN IRELAND
    Naidoo, Jarushka
    Noonan, Sinead
    Teo, Min Yuen
    Rho, Young Soo
    Clince, Janet
    Gately, Kathy
    O'Brien, Cathal
    O'Grady, Tony
    Kaye, Elaine
    Morris, Patrick G.
    O'Byrne, Kenneth
    Breathnach, Oscar S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S692 - S692
  • [43] Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
    Choi, Yong Won
    Choi, Jin-Hyuk
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 422 - 428
  • [44] THE EFFECTS OF EPIDERMAL GROWTH FACTOR (EGFR) RECEPTOR INHIBITORS ON THE IMMUNE SYSTEM IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Meniawy, Tarek
    Lake, Richard
    Nowak, Anna K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S374 - S374
  • [45] Effect of Local Therapy on Survival in Oligometastatic Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer (NSCLC)
    Soon, Y. Y.
    Lee, C. C.
    Koh, W. Y.
    Leong, C. N.
    Tey, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S356 - S356
  • [46] Frequency of epidermal growth factor receptor (EGFR) mutations in stage IB-IIIA EGFR mutation positive non-small cell lung cancer (NSCLC) after complete tumour resection
    Tsuboi, M.
    Herbst, R. S.
    John, T.
    Grohe, C.
    Majem, M.
    Goldman, J. W.
    Kim, S-W.
    Yu, C-J.
    Miziara, J. E. A.
    Novello, S.
    Urban, D.
    Akewanlop, C.
    Ozturk, A.
    Quang, B. V.
    Kowalski, D.
    Marmol, D.
    Marotti, M.
    Laus, G.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2019, 30 : 589 - 589
  • [47] EGFR Mutation in Non-Small Cell Lung Cancer is Influenced by EGFR Amplification and Biomarkers
    Pollen, M.
    Waterman, J. P.
    Ding, M.
    Alvarez, A.
    Boyd, M.
    Streifel, J.
    Noroberg, M. L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 655 - 655
  • [48] Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)
    Paulina Bracht, Jillian Wilhelmina
    Karachaliou, Niki
    Berenguer, Jordi
    Pedraz-Valdunciel, Carlos
    Filipska, Martyna
    Codony-Servat, Carles
    Codony-Servat, Jordi
    Rosell, Rafael
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (12): : 2607 - 2614
  • [49] Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors
    Karachaliou, Niki
    Rosell, Rafael
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (03) : 114 - 117
  • [50] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CO-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND RESPONSE TO EGFR TYROSINE KINASE INHIBITORS (TKIS)
    Barnet, Megan B.
    O'Toole, Sandra
    Horvath, Lisa' G.
    Selinger, Christina
    Yu, Bing
    Trent, Ronald
    Ng, Chiu Chin
    Boyer, Michael J.
    Cooper, Wendy
    Kao, Steven
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 156 - 156